Select a Region North America

Optimize Launch Performance

66% of life science product launches don’t meet expectations

A Holistic, Agile Model

Companies spend more than $200 million over three years leading up to a launch and $10MM in internal headcount. Rising costs and industry pressures now require a more advanced commercialization model to ensure long-term commercial success and sustainable value for key stakeholders.

From industry-leading patient services and adherence solutions to global pricing and revenue management, EVERSANA’s end-to-end life sciences commercialization model increases speed to market and accelerates growth for pharmaceutical, medical device, and digital therapies.

Ensure Optimal Commercialization

EVERSANA’s comprehensive suite of commercial services powered by Data & Analytics help navigate product launches in this new era with confidence: 

  • Create informed strategies from early in development to launch with speed and certainty
  • Improve patient outcomes and identify opportunities to lower total cost of care
  • Inform healthcare and clinical decision-making at launch and accelerate access for patients
  • Generate regulatory-grade evidence to quantify the economic and clinical value of healthcare interventions to payers, providers, and patients

EVERSANA is the Only Go-To Expert in the Industry Offering a COMPLETE Commercialization Model.

Purposefully Built to Act as Your Commercialization Engine

Imagine not having to risk building an expensive infrastructure – because we have built a foundation you can customize for your product needs. Activate a complete, ready-to-deploy, high-performance commercialization and distribution engine today!

EVERSANA COMPLETE Commercialization Operating Model

Learn more about EVERSANA COMPLETE COMMERCIALIZATION.


 

Or use our solutions to optimize your launch and achieve your commercial goals

  • Market Assessment & Insights

    Market Assessment & Insights

    The intelligence you need to validate or inform your strategy across the product life cycle.

    Learn More
  • Market Access Strategy & Stakeholder Engagement

    Market Access Strategy & Stakeholder Engagement

    Breaking down the complexity of reimbursement and access. Engaging the Patient, Payer and Provider.

    Learn More
  • Global Pricing Data & Software

    Global Pricing Data & Software

    Assess your pricing and launch strategies globally. Answer the complex questions impacting your revenue.

    Learn More
  • Global Channel Distribution

    Global Channel Distribution

    Agile, all-inclusive supply chain model proven to maximize profits.

    Learn More
  • Affordability, Access & Hub

    Affordability, Access & Hub

    Automated Processes Reduce Access Barriers & Simplify Onboarding

    Learn More
  • Management Consulting

    Management Consulting

    Strategies to support global launches and address complexities across markets.

    Learn More

Metrics Matter

  • 97%
    Covered lives access within four months of launch
  • 600+
    Product Launches Supported by our Channel Business
  • 95.3%
    Patient Compliance New Rare Drug Launch
  • 1000
    Lives Saved Therapy reaches patients in less than 8 hours, 24-7, 365 days a year

Client Success Stories

  • Rare Disease Launch

    Optimized the launch of a first-to-market orphan therapy with complex access and adherence challenges.

    Learn More
  • Speed to Therapy

    Reduced access barriers and simplified patient onboarding for faster therapy initiation.

    Learn More

Contact Us

QUESTIONS? REACH OUT TO OUR EXPERTS